Stay updated on Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.

Latest updates to the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded a consolidated Locations section listing Barcelona and Tarragona. The previous separate 'Barcelona Locations' and 'Tarragona Locations' headings have been replaced (revision: v3.3.3).SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange Detected- The page now displays Revision: v3.3.2, replacing Revision: v3.2.0. - This appears to be a minor version update with no changes to the study content or its presentation beyond labeling.SummaryDifference0.0%

- Check39 days agoChange DetectedRemoved the temporary government funding status notice; this change does not affect study details, enrollment information, or page functionality, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedNo significant changes detected between the two screenshots. The page content and structure appear unchanged for the COMETA-Breast study details on ClinicalTrials.gov.SummaryDifference0.4%

- Check75 days agoChange Detected- Added a government-status notice and links, indicating current operating status and potential processing delays. - Updated revision version from v3.1.0 to v3.2.0. No other significant content changes detected.SummaryDifference2%

- Check89 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.0%

Stay in the know with updates to Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.